Navigation Links
iCAD Achieves Record-High Ratings in Mammography CAD User Satisfaction
Date:7/10/2008

Continues to Surpass Competition in Most Categories of Customer

Satisfaction, According to MD Buyline

NASHUA, N.H., July 10 /PRNewswire-FirstCall/ -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early detection of cancer, today announced that the Company has achieved record-high customer satisfaction ratings in the Mammography CAD market, according to the independent healthcare research group MD Buyline.

In MD Buyline's User Satisfaction Report for the first two quarters of 2008, iCAD remains #1 in mammography CAD for user satisfaction in system performance, system reliability, installation/implementation, applications training, service response time and service repair quality compared to Hologic/R2. Additionally, iCAD has attained record-high customer service ratings in the categories of System Reliability, Service Repair Quality and overall service and quality.

"We are pleased to see that according to these results, we have been able to maintain the industry's best customer satisfaction ratings this year," said Ken Ferry, President and CEO of iCAD, Inc. "It is even more exciting for iCAD to have achieved its all time high rankings for several of the categories in the report. iCAD is dedicated to delivering superior CAD solutions and customer service that enable radiologists to detect the hardest to find cancers earlier. We thank iCAD users for these high rankings and will continue our mission of providing our customers with first class service and support."

About MD Buyline

MD Buyline provides the most comprehensive database of information on healthcare products. Their data assists healthcare providers through every phase of the purchasing process from researching Emerging Technologies to final negotiations. MD Buyline members use the data to make informed decisions, which enables cost savings and operational efficiencies. For MDBuyline, contact Rod Faulkner, analyst at 214-891-6796 or via e-mail at rod.faulkner @mdbuyline.com

About iCAD, Inc.

iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by more than 2,200 women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com.
For iCAD, contact Darlene Deptula-Hicks at 603-882-5200 x7944, or via email at
ddeptula@icadmed.com For Investor Relations, contact Anne Marie Fields of Lippert/Heilshorn &

Associates at 212-838-3777 x6604 or via email at icad@lhai.com

For Public Relations, contact Jill Testagrossa of Schwartz Communications at

781-684-0770 or via e-mail at icad@schwartz-pr.com

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:

Certain statements contained in this News Release constitute "forward- looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe," "demonstrate," "intend," "expect," "estimate," "anticipate," "likely," and similar expressions identify forward- looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release.


'/>"/>
SOURCE iCAD, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Echocardiography Lab at Presbyterian Hospital of Dallas Achieves Prestigious Reaccreditation
2. Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
3. Companion Data Services Achieves ISO Certification for Quality Management
4. Animal Dermatology Clinic - San Diego Announces Dr. Brett Wildermuth, DVM, Achieves Diplomate Status With the American College of Veterinary Dermatology
5. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
6. All Childrens Hospital Achieves ISBT 128 Compliance With Mediwares HCLL Blood Bank System
7. A guided broncoscope achieves biopsy of 75 percent pulmonary nodules without puncture or surgery
8. Paramed Systems Achieves Significant Business Milestone in the Offshore Oil and Gas Evacuation Market
9. Blue Cross and Blue Shield of North Carolina Achieves Bridges to Excellence Certification
10. Highmark Medicare Services Achieves Certification to COPC-2000(R) CSP Standard
11. GHX Achieves SAS 70 Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology: